What is a stock summary page? Click here for an overview.
Business Description
Inter Pharma PCL
ISIN : TH9474010005
Compare
Compare
Traded in other countries / regions
IP.Thailand IPO Date
2019-11-05Description
Inter Pharma PCL is a biopharmaceutical company. It is engaged in the import, manufacture and distribution of drug, and dietary supplement products for humans and animals. It offers products related to Wellness and Anti-aging, Aesthetics, Diagnostics, Vitamins, and other products. The company operates in three reportable segments Human healthcare, Animal Healthcare, and Hospital and clinics in Thailand. Key revenue is derived from the Human healthcare segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | 2.13 | |||||
| Interest Coverage | 3.81 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.47 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17.9 | |||||
| 3-Year EBITDA Growth Rate | -5.5 | |||||
| 3-Year EPS without NRI Growth Rate | -34.6 | |||||
| 3-Year FCF Growth Rate | 38.3 | |||||
| 3-Year Book Growth Rate | 26.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.1 | |||||
| 9-Day RSI | 53.02 | |||||
| 14-Day RSI | 57.76 | |||||
| 3-1 Month Momentum % | -22.29 | |||||
| 6-1 Month Momentum % | -45.54 | |||||
| 12-1 Month Momentum % | -60.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.87 | |||||
| Quick Ratio | 1.24 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 105.53 | |||||
| Days Sales Outstanding | 62.5 | |||||
| Days Payable | 58.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1 | |||||
| Dividend Payout Ratio | 0.56 | |||||
| 3-Year Dividend Growth Rate | 35.7 | |||||
| Forward Dividend Yield % | 1 | |||||
| 5-Year Yield-on-Cost % | 1 | |||||
| 3-Year Average Share Buyback Ratio | -7.7 | |||||
| Shareholder Yield % | 4.59 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.42 | |||||
| Operating Margin % | 3.98 | |||||
| Net Margin % | 1.97 | |||||
| FCF Margin % | -4.41 | |||||
| ROE % | 1.94 | |||||
| ROA % | 1.26 | |||||
| ROIC % | 2.26 | |||||
| 3-Year ROIIC % | -4.28 | |||||
| ROC (Joel Greenblatt) % | 5.42 | |||||
| ROCE % | 2.98 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 56.13 | |||||
| PE Ratio without NRI | 56.13 | |||||
| Price-to-Owner-Earnings | 107.06 | |||||
| PEG Ratio | 3.74 | |||||
| PS Ratio | 1.11 | |||||
| PB Ratio | 1.09 | |||||
| Price-to-Tangible-Book | 1.68 | |||||
| Price-to-Operating-Cash-Flow | 11.84 | |||||
| EV-to-EBIT | 34.25 | |||||
| EV-to-EBITDA | 13.68 | |||||
| EV-to-Revenue | 1.34 | |||||
| EV-to-FCF | -31.45 | |||||
| Price-to-GF-Value | 0.48 | |||||
| Price-to-Projected-FCF | 2.62 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.38 | |||||
| Price-to-Graham-Number | 2.05 | |||||
| Earnings Yield (Greenblatt) % | 2.92 | |||||
| FCF Yield % | -3.96 | |||||
| Forward Rate of Return (Yacktman) % | 13.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inter Pharma PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 1,897.33 | ||
| EPS (TTM) (฿) | 0.062 | ||
| Beta | 1.14 | ||
| 3-Year Sharpe Ratio | -0.65 | ||
| 3-Year Sortino Ratio | -0.91 | ||
| Volatility % | 77.86 | ||
| 14-Day RSI | 57.76 | ||
| 14-Day ATR (฿) | 0.240773 | ||
| 20-Day SMA (฿) | 3.435 | ||
| 12-1 Month Momentum % | -60.15 | ||
| 52-Week Range (฿) | 2.02 - 7.3 | ||
| Shares Outstanding (Mil) | 605.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inter Pharma PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inter Pharma PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inter Pharma PCL Frequently Asked Questions
What is Inter Pharma PCL(BKK:IP)'s stock price today?
The current price of BKK:IP is ฿3.48. The 52 week high of BKK:IP is ฿7.30 and 52 week low is ฿2.02.
When is next earnings date of Inter Pharma PCL(BKK:IP)?
The next earnings date of Inter Pharma PCL(BKK:IP) is .
Does Inter Pharma PCL(BKK:IP) pay dividends? If so, how much?
The Dividend Yield %  of Inter Pharma PCL(BKK:IP) is 1% (As of Today), Highest Dividend Payout Ratio of Inter Pharma PCL(BKK:IP) was 1.32. The lowest was 0.06. And the median was 0.64. The  Forward Dividend Yield % of Inter Pharma PCL(BKK:IP) is 1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers